Stay updated on Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New user guidance sections and a recruitment status update were added to the study page, clarifying participation options and how to navigate the record. A formatting tweak to the Intervention/Treatment heading and the revision label were updated.
    Difference
    0.4%
    Check dated 2026-06-15T15:41:40.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.5, indicating an internal update to the page rendering or content management system.
    Difference
    0.0%
    Check dated 2026-06-08T15:15:12.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added update dates 2026-05-20, 2026-05-05, and 2026-05. Removed 2025-11-18, 2025-11-05, and 2025-11, reflecting changes to the page's revision history.
    Difference
    0.2%
    Check dated 2026-05-25T06:29:34.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added the page revision tag v3.5.4 to replace the previous v3.5.3, indicating the page was updated. This update appears to reflect a revision history change rather than content changes to the study details.
    Difference
    0.0%
    Check dated 2026-05-18T03:46:18.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page’s displayed revision number has been updated from v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:23:40.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T20:05:10.000Z thumbnail image

Stay in the know with updates to Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec & Pembrolizumab in Melanoma Clinical Trial page.